JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB221154

Anti-TIE2 antibody [EPR21915]

Be the first to review this product! Submit a review

|

(11 Publications)

Anti-TIE2 antibody [EPR21915] (ab221154) is a rabbit monoclonal antibody detecting TIE2 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, ICC/IF, ELISA. Suitable for Human, Mouse.

- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

CD202b, TIE2, VMCM, VMCM1, TEK, Angiopoietin-1 receptor, Endothelial tyrosine kinase, Tunica interna endothelial cell kinase, Tyrosine kinase with Ig and EGF homology domains-2, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE-2, p140 TEK, hTIE2

10 Images
Flow Cytometry - Anti-TIE2 antibody [EPR21915] (AB221154)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-TIE2 antibody [EPR21915] (AB221154)

Flow cytometric analysis of HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) (left panel) and HUVEC (human umbilical vein endothelial cell line) (right panel) cells labeling TIE2 with ab221154 at 1/500 dilution (red) compared with a Rabbit monoclonal IgG (ab172730) Isotype control (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077), at 1/2000 dilution was used as the secondary antibody.

Gated on viable cells.

Negative control : HEK - 293T (PMID : 17189382)

Immunocytochemistry/ Immunofluorescence - Anti-TIE2 antibody [EPR21915] (AB221154)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-TIE2 antibody [EPR21915] (AB221154)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HUVEC (human umbilical vein endothelial cell line) cells labeling TIE2 with ab221154 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous and cytoplasmic staining in HUVEC cell line is observed. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).

Control : Used PBS instead of primary antibody, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Negative control : HEK-293T (PMID : 17189382).

Flow Cytometry (Intracellular) - Anti-TIE2 antibody [EPR21915] (AB221154)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-TIE2 antibody [EPR21915] (AB221154)

Flow cytometry overlay histogram showing positive HUVEC cells (left) and negative Hek-293 cells (right) stained with ab221154 (red line). The cells were fixed with 4% PFA and permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab221154) (1x 106 in 100μl at 0.2 μg/ml (1/2,500)) for 30min at 22°C.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C.

Isotype control antibody Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control was used at the same concentration and conditions as the primary antibody (black line). Unlabelled sample was also used as a control (blue line).

Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.

Indirect ELISA - Anti-TIE2 antibody [EPR21915] (AB221154)
  • I-ELISA

Lab

Indirect ELISA - Anti-TIE2 antibody [EPR21915] (AB221154)

Indirect ELISA showing primary antibody ab221154 binding to mouse TEK and Human TEK. Antigen concentration is 1000 ng/ml. Binding of ab221154 was assessed in a serial dilution range 1000-0 ng/ml. Binding was detected using the secondary antibody, Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution.

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)
  • WB

Supplier Data

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The identity of the bands lower than 100 kDa are unknown.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-TIE2 antibody [EPR21915] - (ab221154) staining at 1/500 dilution.

All lanes:

Western blot - Anti-TIE2 (phospho Y992) antibody [EPR27958-1] (<a href='/en-us/products/primary-antibodies/tie2-phospho-y992-antibody-epr27958-1-ab321883'>ab321883</a>) at 1/1000 dilution

Lane 1:

Untreated HUVEC (human umbilical vein endothelial cell) whole cell lysate (untreated membrane) at 20 µg

Lane 2:

HUVEC treated with 100 uM Pervanadate for 10 minutes whole cell lysate (untreated membrane) at 20 µg

Lane 3:

HUVEC treated with 100 uM Pervanadate for 10 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 36 kDa,126 kDa

false

Exposure time: 103s

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)
  • WB

Lab

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

To preserve protein degradation, harvested cells were immediately lysed, followed by rapid gel electrophoresis and membrane transfer procedures.

All lanes:

Western blot - Anti-TIE2 antibody [EPR21915] (ab221154) at 1/1000 dilution

Lane 1:

HUVEC (human umbilical vein endothelial cell line) fresh whole cell lysate at 20 µg

Lane 2:

HUVEC (human umbilical vein endothelial cell line) frozen whole cell lysate at 20 µg

Lane 3:

Mouse lung fresh tissue lysate at 20 µg

Lane 4:

Mouse lung frozen tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 160 kDa,60 kDa

false

Exposure time: 180s

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)
  • WB

Lab

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The antibody ab221154 exhibits low sensitivity in Western blot analyses. To improve detection of full-length TIE2, we recommend substituting with ab307556 or ab259982. Alternatively, experimental conditions can be optimized through increasing sample loading quantity, using lower antibody dilution or implementing femtogram-level sensitivity detection substrates.

Important note : TIE2 undergoes proteolytic cleavage (PMID : 32838837, PMID : 26666854). These three antibodies target distinct cleaved fragments of TIE2 due to differences in their immunogen localization.

Lane 1:

Western blot - Anti-TIE2 antibody [EPR21915] (ab221154)

Lane 2:

Western blot - Anti-TIE2 antibody [EPR26540-78] (<a href='/en-us/products/primary-antibodies/tie2-antibody-epr26540-78-ab307556'>ab307556</a>)

Lane 3:

Western blot - Anti-TIE2 antibody [EPR23823-109] (<a href='/en-us/products/primary-antibodies/tie2-antibody-epr23823-109-ab259982'>ab259982</a>)

All lanes:

HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 60 kDa,40 kDa,160 kDa

false

Exposure time: 40s

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)
  • WB

Unknown

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)

Blocking and dilution buffer : 5% NFDM/TBST.

The molecular mass observed is consistent with what has been described in the literature (PMID : 26666854). The antibody detects multiple bands (≤ 50 kDa) which are likely to be cleavage fragments of Tie2.

Negative control : HEK-293T (PMID : 15851516).

This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.

All lanes:

Western blot - Anti-TIE2 antibody [EPR21915] (ab221154) at 1/100000 dilution

Lane 1:

Human lung tissue lysate at 20 µg

Lane 2:

HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 20 µg

Lane 3:

U-87 MG (human glioblastoma-astrocytoma epithelial cell line) whole cell lysate at 20 µg

Lane 4:

HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution

Predicted band size: 125 kDa

Observed band size: 40 kDa,50 kDa,160 kDa

true

Exposure time: 3min

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)
  • WB

Lab

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The antibody ab221154 exhibits low sensitivity in Western blot analyses. To improve detection of full-length TIE2 in mouse samples, we recommend substituting with ab307556. Alternatively, experimental conditions can be optimized through increasing sample loading quantity, using lower antibody dilution or implementing femtogram-level sensitivity detection substrates.

To preserve protein degradation, harvested cells were immediately lysed, followed by rapid gel electrophoresis and membrane transfer procedures.

Lanes 1 and 3:

Western blot - Anti-TIE2 antibody [EPR21915] (ab221154) at 1/1000 dilution

Lanes 2 and 4:

Western blot - Anti-TIE2 antibody [EPR26540-78] (<a href='/en-us/products/primary-antibodies/tie2-antibody-epr26540-78-ab307556'>ab307556</a>) at 1/1000 dilution

Lanes 1 - 2:

bEnd.3 (mouse brain endothelial cell) fresh whole cell lysate at 20 µg

Lanes 3 - 4:

bEnd.3 (mouse brain endothelial cell) frozen whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 160 kDa

false

Exposure time: 180s

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)
  • WB

Lab

Western blot - Anti-TIE2 antibody [EPR21915] (AB221154)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The antibody ab221154 exhibits low sensitivity in Western blot analyses. To improve detection of full-length TIE2 in mouse samples, we recommend substituting with ab307556. Alternatively, experimental conditions can be optimized through increasing sample loading quantity, using lower antibody dilution or implementing femtogram-level sensitivity detection substrates.

Lane 1:

Western blot - Anti-TIE2 antibody [EPR21915] (ab221154) at 1/1000 dilution

Lane 2:

Western blot - Anti-TIE2 antibody [EPR26540-78] (<a href='/en-us/products/primary-antibodies/tie2-antibody-epr26540-78-ab307556'>ab307556</a>) at 1/1000 dilution

All lanes:

Mouse lung tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 160 kDa

false

Exposure time: 180s

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-TIE2 antibody [EPR21915]

  • Carrier free

    Anti-TIE2 antibody [EPR21915] - BSA and Azide free

  • 578 PE

    PE Anti-TIE2 antibody [EPR21915]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-TIE2 antibody [EPR21915]

  • 660 APC

    APC Anti-TIE2 antibody [EPR21915]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21915

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse

Applications

I-ELISA, ICC/IF, Flow Cyt (Intra), WB, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

ab221154 shows low sensitivity in detecting full length of TIE2, we recommend using ab307556 or ab259982 as alternatives for detecting of full length of TIE2.

TIE2 undergoes proteolytic cleavage (PMID: 32838837, PMID: 26666854). ab221154 is more sensitive in detecting C-terminal fragment at 60kDa.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/2500", "FlowCytIntra-species-notes": "<p></p>", "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "0.25 µg/mL", "IELISA-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/4000", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "0.25 µg/mL", "IELISA-species-notes": "<p></p>", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-TIE2 antibody [EPR21915] (ab221154) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Human, Mouse samples.

What is the molecular weight of TIE2?
Anti-TIE2 [EPR21915] (ab221154) specifically detects a band for TIE2 (UniProt: Q02763) at a molecular weight of 126kDa.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR21915] also available for your convenience: ab221154, Carrier free - ab238172, Alexa Fluor® 647 - ab306575, Alexa Fluor® 488 - ab307374, PE - ab307642, APC - ab314268

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TIE2 also known as TEK or CD202B is a receptor tyrosine kinase with a mass of approximately 145 kDa. It plays an important role in vascular development and maintenance. TIE2 is mainly expressed in endothelial cells which line the interior surface of blood vessels. It binds angiopoietins predominantly Angiopoietin-1 (Angpt1) influencing vascular stability and permeability. Researchers use TIE2 antibodies including anti-TIE and anti-clone to study its role and functions across various contexts.
Biological function summary

TIE2 plays a central role in angiogenesis and blood vessel maturation. It forms a receptor complex with other components to mediate its effects. This interaction mainly involves Angpt1 which binds to TIE2 stabilizing blood vessels and preserving their integrity. TIE2 also participates in cell survival and migration processes necessary for normal vascular function. Researchers often perform Angpt1 ELISA in bulk to quantify interactions involving TIE2 in experiments.

Pathways

TIE2 is important in the angiopoietin-TIE signaling pathway regulating vascular development. TIE2 is related to proteins such as Angpt1 which are centrally involved in this pathway. It also interacts with various signaling molecules including phosphatidylinositol-3-kinase (PI3K) which contributes to cell survival pathways. Alterations in the TIE2 signaling cascade can lead to aberrant angiogenesis and related pathologies.

TIE2 is implicated in several vascular diseases and cancer. Mutations or dysregulation of TIE2 can result in venous malformations and further compromise blood vessel integrity. In cancer TIE2 expression can influence tumor angiogenesis enhancing tumor growth and metastasis. TIE2 interacts with proteins like vascular endothelial growth factor (VEGF) which are involved in neovascularization and cancer progression. Understanding these interactions helps target therapeutic strategies in relevant diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Tyrosine-protein kinase that acts as a cell-surface receptor for ANGPT1, ANGPT2 and ANGPT4 and regulates angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Has anti-inflammatory effects by preventing the leakage of pro-inflammatory plasma proteins and leukocytes from blood vessels. Required for normal angiogenesis and heart development during embryogenesis. Required for post-natal hematopoiesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. ANGPT1 signaling triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Signaling is modulated by ANGPT2 that has lower affinity for TEK, can promote TEK autophosphorylation in the absence of ANGPT1, but inhibits ANGPT1-mediated signaling by competing for the same binding site. Signaling is also modulated by formation of heterodimers with TIE1, and by proteolytic processing that gives rise to a soluble TEK extracellular domain. The soluble extracellular domain modulates signaling by functioning as decoy receptor for angiopoietins. TEK phosphorylates DOK2, GRB7, GRB14, PIK3R1; SHC1 and TIE1.
See full target information TEK

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Cell & bioscience 15:62 PubMed40399921

2025

Tie2-expressing monocytes/macrophages promote angiogenesis in chronically ischaemic brain tissue.

Applications

Unspecified application

Species

Unspecified reactive species

Chuyang Tai,Cong Ling,Yang Yang,Baoyu Zhang,Jun Sun,Ni Mo,Tao Sun,Lixin Huang,Cian Yao,Hui Wang,Chuan Chen

Stem cell research & therapy 16:70 PubMed39940043

2025

Pericyte-derived extracellular vesicles improve vascular barrier function in sepsis via the Angpt1/PI3K/AKT pathway and pericyte recruitment: an in vivo and in vitro study.

Applications

Unspecified application

Species

Unspecified reactive species

Zi-Sen Zhang,Ao Yang,Xi Luo,He-Nan Zhou,Yi-Yan Liu,Dai-Qin Bao,Jie Zhang,Jia-Tao Zang,Qing-Hui Li,Tao Li,Liang-Ming Liu

Nature communications 15:5550 PubMed38956014

2024

Maternal mRNA deadenylation is defective in in vitro matured mouse and human oocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Yusheng Liu,Wenrong Tao,Shuang Wu,Yiwei Zhang,Hu Nie,Zhenzhen Hou,Jingye Zhang,Zhen Yang,Zi-Jiang Chen,Jiaqiang Wang,Falong Lu,Keliang Wu

Cell proliferation 57:e13548 PubMed37749923

2023

Pyruvate kinase M2 regulates kidney fibrosis through pericyte glycolysis during the progression from acute kidney injury to chronic kidney disease.

Applications

Unspecified application

Species

Unspecified reactive species

Yulan Chen,Xueyuan Bai,Jianwen Chen,Mengjie Huang,Quan Hong,Qing Ouyang,Xuefeng Sun,Yan Zhang,Jiaona Liu,Xu Wang,Lingling Wu,Xiangmei Chen

Frontiers in cell and developmental biology 11:1178045 PubMed37274734

2023

Role of UDP-glucose ceramide glucosyltransferase in venous malformation.

Applications

Unspecified application

Species

Unspecified reactive species

Sheng Chen,Yuan Wang,Liangliang Kong,Yi Ji,Jie Cui,Weimin Shen

Frontiers in oncology 12:974573 PubMed36110967

2022

Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential and .

Applications

Unspecified application

Species

Unspecified reactive species

Ziruizhuo Zhang,Songcheng Zhang,Bingjie Lin,Qixin Wang,Xiaojing Nie,Yonghua Shi

International journal of molecular sciences 23: PubMed35409417

2022

Direct Reprogramming and Induction of Human Dermal Fibroblasts to Differentiate into iPS-Derived Nucleus Pulposus-like Cells in 3D Culture.

Applications

Unspecified application

Species

Unspecified reactive species

Shoji Seki,Mami Iwasaki,Hiroto Makino,Yasuhito Yahara,Yoshitaka Miyazaki,Katsuhiko Kamei,Hayato Futakawa,Makiko Nogami,Nguyen Tran Canh Tung,Tatsuro Hirokawa,Mamiko Tsuji,Yoshiharu Kawaguchi

Cell biology international 45:1876-1886 PubMed33945659

2021

miR-25-5p regulates endothelial progenitor cell differentiation in response to shear stress through targeting ABCA1.

Applications

Unspecified application

Species

Unspecified reactive species

Zhe Li,Jia-Nan Li,Qiang Li,Chun Liu,Lin-Hua Zhou,Qi Zhang,Yi Xu

Cell proliferation 54:e13055 PubMed33987885

2021

Activated mesangial cells induce glomerular endothelial cells proliferation in rat anti-Thy-1 nephritis through VEGFA/VEGFR2 and Angpt2/Tie2 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yinghua Zhao,Bo Fu,Pu Chen,Qinggang Li,Qing Ouyang,Chuyue Zhang,Guangyan Cai,Lingling Wu,Xiangmei Chen

International journal of nanomedicine 16:1961-1976 PubMed33727809

2021

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jialang Zhuang,Siqi Chen,Ye Hu,Fan Yang,Qin Huo,Ni Xie
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com